Mercy Family Health introduces StemWave Shockwave Treatment for peripheral neuropathy, using acoustic pulses to heal damaged nerves rather than mask symptoms. Clinical observations show 85% of chronic pain patients benefit from this alternative to conventional pain management.
-- Mercy Family Health has introduced StemWave Shockwave Treatment for peripheral neuropathy patients seeking alternatives to conventional pain management. This therapy uses acoustic pulses to stimulate healing processes in damaged nerves, addressing underlying nerve damage rather than masking symptoms.
For more information about StemWave Shockwave Treatment, visit https://www.americastruehealth.com/blog/stemwave-shockwave-therapy-and-hope-for-peripheral-neuropathy
Peripheral neuropathy affects millions of Americans, particularly those with diabetes. The condition damages nerves outside the brain and spinal cord, most commonly affecting sensory nerves in the feet and hands. Patients typically experience numbness, painful burning or stabbing sensations, loss of balance, and in some cases, muscle weakness when motor nerves are involved.
Traditional medical approaches have relied primarily on pain medications or seizure medications to control symptoms. These treatments often fail to address the progressive nature of the condition, which typically worsens over time and significantly diminishes quality of life and physical function.
The StemWave system represents a specific type of shockwave technology that delivers precisely calibrated acoustic pulses to affected areas. This stimulation promotes nerve tissue regeneration and reduces inflammation, potentially restoring sensation and function in damaged nerves. Unlike conventional treatments, StemWave targets the underlying nerve damage rather than simply managing pain.
Clinical observations indicate that approximately 85% of chronic pain patients benefit from StemWave treatments. Most patients require between 8 and 15 sessions, though results vary by individual. The therapy has demonstrated positive outcomes for neuropathy from various causes, including diabetes and chemotherapy side effects.
For patients with idiopathic neuropathy—cases where extensive testing yields no clear cause—StemWave offers a potential path forward when traditional medicine has reached its limits. The treatment has shown particular promise in restoring positional sensation and improving balance in patients who previously experienced frequent falls due to sensory deficits.
Dr. Stanley Lang, a board-certified family physician with over 40 years of experience, and Sheri Lang, CRNP, a Certified Nurse Practitioner with international healthcare experience, lead Mercy Family Health and Regenerative Pain Management. Their approach combines StemWave therapy with complementary measures addressing diet, biomechanics, and lifestyle factors for comprehensive neuropathy care in Western Pennsylvania.
For additional information about Mercy Family Health and their healthcare services including Regenerative Pain Management, visit https://www.americastruehealth.com.
Contact Info:
Name: Stanley Lang
Email: Send Email
Organization: Highroad Enterprises
Address: 531 Delarme Road, DuBois, PA 15801, United States
Website: https://rxlyme.com/
Source: NewsNetwork
Release ID: 89168408
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.
